USPTO 2015–2025 USPTO PatentsView Foreign Corporation

AnnJi Pharmaceutical Co., Ltd.

USPTO PatentsView assignee record - 7 granted patents across 3 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, Annji ranks #34,253 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 3 technology areas.

#34,253
of 49,997 US assignees by volume
Top 45%
by Innovation Score (36.8/100)
17.0
avg claims per patent
-60%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R34253 · Foreign Corporation #34,253 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 7 grants
  • MID-PACK #34,253/49,997
  • PHOTO-FINISH Andritz Perfojet SAS
  • CPC-NARROW A61P · 3 areas
  • INNOV-THIN 36.8/100
  • CLAIMS-RICH 17.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -60% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Andritz Perfojet SAS (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Annji

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Annji's Innovation Score is 36.8/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Annji's grants concentrate

AnnJi Pharmaceutical Co., Ltd. is a focused PatentsView assignee: 3 CPC subclasses with 85.7% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (3 grants) versus a trough of 2 in 2016. By volume, Annji sits between Andritz Perfojet SAS and Apex Technologies, Inc..

Annji's three-year grant acceleration

AnnJi Pharmaceutical Co., Ltd. shows 2 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at AnnJi's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows AnnJi holds 7 patents at rank #34,329, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near AnnJi

By rank, the assignees closest to #34,329 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in AnnJi's primary technology class.

Annji's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 45% higher than 55% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

1.522.533.5 201520162022 2
USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
AnnJi Pharmaceutical Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 42.9%
2016 2 28.6%
2022 2 28.6%

Where it ranks

Overall rank by patents

#34,253

of 49,997 tracked assignees

Innovation Score

36.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

AnnJi Pharmaceutical Co., Ltd.'s patent record in context - here's where to go next.

  • AnnJi Pharmaceutical Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 85.7% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #34,253 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare AnnJi Pharmaceutical Co., Ltd. against Andritz Perfojet SAS, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 36.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.